Table 2 Summary of AEs and bivalirudin-related ADRs
Items | Incidence, No. (%) |
|---|---|
Total AEs | 120 (13.1) |
 SAEs | 7 (0.8) |
  Hospitalization | 4 (0.4) |
  Death | 2 (0.2) |
  Other important medical events | 1 (0.1) |
Total bivalirudin-related ADRs | 40 (4.4) |
 SADRs | 3 (0.3) |
  Hospitalization | 1 (0.1) |
  Death | 0 (0.0) |
  Other important medical events | 2 (0.2) |
 Thrombocytopenia | 27 (2.9) |
 Bleeding | 13 (1.4) |